Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer
Molecular Oncology · 2024
DOI: 10.1002/1878-0261.13659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Yi-Cheng Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Extracellular Vesicles, Glutathione Transferase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, China Medical University, China Medical University Hospital.
Abstract (Originalsprache)
Bladder cancer poses a significant challenge to chemotherapy due to its resistance to cisplatin, especially at advanced stages. Understanding the mechanisms behind cisplatin resistance is crucial for improving cancer therapy. The enzyme glutathione S ‐transferase omega class 1 (GSTO1) is known to be involved in cisplatin resistance in colon cancer. This study focused on its role in cisplatin resistance in bladder cancer. Our analysis of protein expression in bladder cancer cells stimulated by secretions from tumor‐associated macrophages (TAMs) showed a significant increase in GSTO1. This prompted further investigation into the role of GSTO1 in bladder cancer. We found a strong correlation between GSTO1 expression and cisplatin resistance. Mechanistically, GSTO1 triggered the release of large extracellular vesicles (EVs) that promoted cisplatin efflux, thereby reducing cisplatin–DNA adduct formation and enhancing cisplatin resistance. Inhibition of EV release effectively counteracted the cisplatin resistance associated with GSTO1. In conclusion, GSTO1‐mediated EV release may contribute to cisplatin resistance caused by TAMs in bladder cancer. Strategies to target GSTO1 could potentially improve the efficacy of cisplatin in treating bladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan.
- Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung, Taiwan.
- Division of Hematology and Oncology, Department of Internal Medicine, China Medical University, Hospital, China Medical University, Taichung, Taiwan.
- Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.
- Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
- Ph.D. Program in Translational Medicine, College of Medicine, Kaohsiung Medical University, Taiwan.
ORCID-Profile: Yi-Cheng Pan, Wei-Chao Chang, Yang-Chang Wu
Förderung
- National Science and Technology Council, Taiwan
- China Medical University
- China Medical University Hospital
- National Science and Technology Council
Zitieren
APA
Pan, Y. C., Chu, P. Y., Lin, C. C., Hsieh, C. Y., Hsu, W. Y., Shyur, L. F., Yang, J. C., Chang, W. C., & Wu, Y. C. (2024). Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.13659
Vancouver
Pan YC, Chu PY, Lin CC, Hsieh CY, Hsu WY, Shyur LF, et al. Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer. Molecular Oncology. 2024. doi:10.1002/1878-0261.13659
BibTeX
@article{Pan2024,
author = {Pan, Yi-Cheng and Chu, Pei-Yi and Lin, Ching-Chan and Hsieh, Ching-Yun and Hsu, Wei-Yu and Shyur, Lie-Fen and Yang, Juan-Cheng and Chang, Wei-Chao and Wu, Yang-Chang},
title = {Glutathione S ‐transferase omega class 1 ( GSTO1 )‐associated large extracellular vesicles are involved in tumor‐associated macrophage‐mediated cisplatin resistance in bladder cancer},
journal = {Molecular Oncology},
year = {2024},
doi = {10.1002/1878-0261.13659}
}
EUVIMED